Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

2 treatments under study, led by Sr1 Laser

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results50% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed1
Terminated1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Sr1 Laser1
  • Picoplus Laser System1

Active Sponsors

  • AVAVA, Inc.1
  • CynosureLutronic1

Top Investigators

Related Conditions

  • Melasma1
  • Wrinkle1
  • Tattoo Pigmentation1

Activity Timeline